Naloxegol for the Prevention of Constipation in Postoperative Spinal Surgery Patients
Status:
Terminated
Trial end date:
2018-02-01
Target enrollment:
Participant gender:
Summary
Constipation is a known complication of the postoperative period after spinal surgery, where
prescription pain medicines called opioids are traditionally used in high doses for the
treatment of surgery-related pain. The goal of this study is to determine the effectiveness
of Movantik (naloxegol)-a FDA-approved drug used to treat constipation that is caused by
opioids-in preventing constipation in patients undergoing spinal fusion surgery at MGH.